Tuberous sclerosis, type 2

Search Trials
Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Status:
Recruiting
Last Changed:
Sep 21, 2021
First Changed:
Feb 1, 2019
Disease(s):
Facial Angiofibroma
Intervention(s):
rapamycinplacebo
Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
Status:
Recruiting
Last Changed:
May 6, 2021
First Changed:
Dec 6, 2017
Disease(s):
Angiofibroma of Face
Intervention(s):
Sirolimus 0.2%Sirolimus 0.4%Placebo ointment
Familial Investigations of Childhood Cancer Predisposition
Status:
Recruiting
Last Changed:
May 12, 2021
First Changed:
Feb 10, 2017
Disease(s):
Acute Leukemia

Connect. Empower. Inspire.